This week, we're diving into the transformative power of AI, from reshaping customer interactions to streamlining pharmaceutical pathways. Discover how an insurer is leveraging GenAI to revolutionize their digital contact center; and tune in to a new podcast that unpacks AI's pivotal role in the pharma industry. Plus, don't miss our analysis on how to enhance Europe’s attractiveness to foreign investors.
In this episode of the EY Health Sciences and Wellness Experience podcast, host Patrick T. O’Sullivan discusses how AI is currently being used to support pharmaceutical manufacturing and supply chain.
In this edition, cross-border mergers and acquisitions (M&A), life sciences as a geopolitical sector, new European Parliament, Mexican election, and more.
EY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets.
Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate.
Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit
ey.com.
This material has been prepared for general informational purposes only and is not intended to be relied upon as accounting, tax, legal or other professional advice. Please refer to your advisors for specific advice.
